V-GO: cost and payments to doctors
What Medicare Part D paid pharmacies for V-GO, and the payments that named it as the associated device or medical supply under the Sunshine Act for program years 2019–2025.
Part D cost for V-GO formulations
Medicare reports V-GO under its specific formulations, which are priced separately.
- v go 40$511per 30-day fill · 6,309 claims · Sub-Q Insulin Device, 40 Unit
- v go 20$509per 30-day fill · 6,181 claims · Sub-Q Insulin Device, 20 Unit
- v go 30$508per 30-day fill · 5,079 claims · Sub-Q Insulin Device, 30 Unit
Paid to pharmacies by Part D plans and patients — not your cost, and not paid to the prescriber. Is this wrong?
Was your doctor paid by Valeritas, Inc.?
Valeritas, Inc. reported the most payments naming V-GO. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $803K
- Providers
- 2,267
- Transactions
- 8,096
- Average per transaction
- $99
The per-transaction average — $99 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,267 providers the average total is $354, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Valeritas, Inc. | $560,248 | 69.8% |
| Mannkind Corporation | $151,634 | 18.9% |
| Zealand Pharma US, Inc. | $90,836 | 11.3% |